Case Report: Transforming small cell lung cancer: two cases report and literature review

Transformation of non-small cell lung cancer (NSCLC) to small cell lung cancer (SCLC) is a relatively rare event with an incidence of about 3%-14%. Due to the poor treatment outcomes and prognosis associated with this transformation, understanding its underlying mechanisms is crucial for improving the diagnosis, management, and prognosis of transformed small cell lung cancer (T-SCLC). In this paper, we present two cases of T-SCLC and review the molecular mechanisms, clinical features, and treatment strategies post-transformation. We emphasize the importance of considering pathological transformation in cases of resistance to NSCLC treatment, monitoring changes in tumor markers, and conducting a re-biopsy. Finally, we propose effective treatment measures for managing T-SCLC.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2025-04-03
DOI
https://doi.org/10.3389/fonc.2025.1573624
Citations
1
Primary Topic
Lung Cancer Research Studies
Type
article
Field-Weighted Citation Impact
1.05
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Case Report: Transforming small cell lung cancer: two cases report and literature review

Lihong Zhao, Qingxin Zhao, Jing Zhao, Yu Zhao et al.
1 citations
Frontiers in Oncology
Lung Cancer Research Studies
1.05
article

Case Report: Transforming small cell lung cancer: two cases report and literature review

Lihong Zhao, Qingxin Zhao, Jing Zhao, Yu Zhao, Jing Ai, Chunling Ma, Jinlong Liu, Yimeng Qian
article en
1 citations

Abstract

Transformation of non-small cell lung cancer (NSCLC) to small cell lung cancer (SCLC) is a relatively rare event with an incidence of about 3%-14%. Due to the poor treatment outcomes and prognosis associated with this transformation, understanding its underlying mechanisms is crucial for improving the diagnosis, management, and prognosis of transformed small cell lung cancer (T-SCLC). In this paper, we present two cases of T-SCLC and review the molecular mechanisms, clinical features, and treatment strategies post-transformation. We emphasize the importance of considering pathological transformation in cases of resistance to NSCLC treatment, monitoring changes in tumor markers, and conducting a re-biopsy. Finally, we propose effective treatment measures for managing T-SCLC.

Frontiers in OncologyVol. 15
North China University of Science and Technology (CN), Hebei North University (CN), Hebei General Hospital (CN)
Good health and well-being
Openalex Percentile: Top 24%
Lung Cancer Research Studies
1.05
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.